Chronic ssri stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: A potential paradigm shift

Frontiers in Behavioral Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Hertz, Leif ^a   Rothman, Douglas L ^b   Li, Baoman ^a   Peng, Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b YALE UNIVERSITY   (United States)

Author keywords

5 HT2 receptors; Calcium homeostasis; Fluoxetine signaling; Glucose metabolism; Glutamate GABA; Glycogen; Major depression; PLA2

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; FLUOXETINE; GLUCOSE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCOGEN; PHOSPHOLIPASE; SEROTONIN 2B RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMINO ACID METABOLISM; ANTIDEPRESSANT ACTIVITY; ARTICLE; ASTROCYTE CULTURE; BINDING AFFINITY; CAV1.2 GENE; DRUG MECHANISM; DRUG TARGETING; ENERGY METABOLISM; GENE; GENE EXPRESSION; GLUA2 GENE; GLUCOSE METABOLISM; GLUK2 GENE; GLYCOGEN METABOLISM; HUMAN; NONHUMAN; PHOSPHOLIPASE GENE; POTASSIUM METABOLISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SEROTONIN RECEPTOR GENE; SIGNAL TRANSDUCTION;

EID: 84923230726     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00025     Document Type: Article

References (202)

1. Abdallah, C. G., Jiang, L., De Feyter, H. M., Fasula, M., Krystal, J. H., Rothman, D. L., et al. (2014a). Glutamate metabolism in major depressive disorder. Am. J. Psychiatry doi: 10.1176/appi.ajp.2014.14010067. [Epub ahead of print]..
2. Abdallah, C. G., Niciu, M. J., Fenton, L. R., Fasula, M. K., Jiang, L., Black, A., et al. (2014b). Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder. Psychother. Psychosom. 83, 298-307.doi: 10.1159/0003 61078.
3. Agis-Balboa, R. C., Guidotti, A., and Pinna, G. (2014). 5a-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients. Psychopharmacology (Berl) 231, 3569-3580.doi: 10.1007/s00213-014-3567-5.
4. Allaman, I., Fiumelli, H., Magistretti, P. J., and Martin, J. L. (2011). Fluoxetine regulates the expression ofneurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl) 216, 75-84.doi: 10.1007/s00213-011-2190-y.
5. Ampuero, E., Rubio, F. J., Falcon, R., Sandoval, M., Diaz-Veliz, G., Gonzalez, R. E., et al. (2010). Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neuroscience 169, 98-108.doi: 10.1016/j.neuroscience.2010.04.035.
6. Andersen, J., Stuhr-Hansen, N., Zachariassen, L. G., Kolds0, H., Schi0tt, B., Str0mgaard, K., et al. (2014). Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac). Mol. Pharmacol. 85, 703-714.doi: 10.1124/mol.113.091249.
7. Andres, A. L., Regev, L., Phi, L., Seese, R. R., Chen, Y., Gall, C. M., et al. (2013). NMDA receptor activation and calpain contribute to disruption of dendritic spines by the stress neuropeptide CRH. J. Neurosci. 33, 16945-16960.doi: 10.1523/JNEUROSCI.1445-13.2013.
8. Anthony, J. P., Sexton, T. J., and Neumaier, J. F. (2000). Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. J. Neurosci. Res. 61, 82-87.doi: 10.1002/1097-4547(20000701)61:1 <82::aid-jnr10>3.0.co;2-e.
9. Azmitia, E. C., Murphy, R. B., and Whitaker-Azmitia, P. M. (1990). MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release. Brain Res. 510, 97-103.doi: 10.1016/0006-8993(90)90732-q.
10. Azmitia, E. C., and Whitaker-Azmitia, P. M. (1991). Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J. Clin. Psychiatry 52 (Suppl.), 4-16..
11. Baez, M., Kursar, J. D., Helton, L. A., Wainscott, D. B., and Nelson, D. L. (1995). Molecular biology of serotonin receptors. Obes. Res. 3, 441S-447S.doi: 10.1002/j.1550-8528.1995.tb00211.x.
12. Bajbouj, M., Lisanby, S. H., Lang, U. E., Danker-Hopfe, H., Heuser, I., and Neu, P. (2006). Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry 59, 395-400.doi: 10.1016/j.biopsych.2005.07.036.
13. Balboa, M. A., and Balsinde, J. (2002). Involvement of calcium-independent phospholipase A2 in hydrogen peroxide-induced accumulation of free fatty acids in human U937 cells. J. Biol. Chem. 277, 40384-40389.doi: 10.1074/jbc.m206155200.
14. Banasr, M., Chowdhury, G. M., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., et al. (2010). Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol. Psychiatry 15, 501-511.doi: 10.1038/mp.2008.106.
15. Barbon, A., Caracciolo, L., Orlandi, C., Musazzi, L., Mallei, A., La Via, L., et al. (2011). Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels. Neurochem. Int. 59,896905.doi: 10.1016/j.neuint.2011.07.013.
16. Barbon, A., Gervasoni, A., LaVia, L., Orlandi, C., Jaskolski, F., Perrais, D., et al (2008) Human GluR6c, a functional splicing variants of GluR6, is mainly expressed in non-nervous cells. Neurosci. Lett. 434, 77-82.doi: 10.1016/j.neulet.2008.01.049.
17. Barbon, A., Popoli, M., LaVia, L., Moraschi, S., Vallini, I., Tardito, D., et al. (2006). Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol. Psychiatry 59, 713-720.doi: 10.1016/j.biopsych.2005.10.018.
18. Bass, B. L. (2002). RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71, 817-846.doi: 10.1146/annurev.biochem.71.110601.135501.
19. Ben Achour, S., and Pascual, O. (2010). Glia: the many ways to modulate synaptic plasticity. Neurochem. Int. 57, 440-445.doi: 10.1016/j.neuint.2010.02.013.
20. Beurel, E., Mines, M. A., Song, L., and Jope, R. S. (2012). Glycogen synthase kinase-levels and phosphorylation undergo large fluctuations in mouse brain during development. BipolarDisord. 14, 822-830.doi: 10.1111/bdi.12023.
21. Beurel, E., Song, L., and Jope, R. S. (2011). Inhibition of glycogen synthase kinase-is necessary for the rapid antidepressant effect of ketamine in mice. Mol. Psychiatry 16, 1068-1070.doi: 10.1038/mp.2011.47.
22. Bhagwagar, Z., Wylezinska, M., Taylor, M., Jezzard, P., Matthews, P. M., and Cowen, P. J. (2004). Increased brain GABA concentrations following acute administration of selective serotinonin reuptake inhibitor. Am. J. Psychiatry 161, 368-370.doi: 10.1176/appi.ajp.161.2.368.
23. Blier, P., and De Montigny, C. (1983). Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J. Neurosci. 3, 1270-1278..
24. Bonhaus, D. W., Bach, C., DeSouza, A., Salazar, F. H., Matsuoka, B. D., Zuppan, P., et al. (1995). The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol. 115, 622-628.doi: 10.1111/j.1476-5381.1995.tb14977.x.
25. Bradley, C. A., Peineau, S., Taghibiglou, C., Nicolas, C. S., Whitcomb, D. J., Bortolotto, Z. A., et al. (2012). A pivotal role of GSK-3 in synaptic plasticity. Front. Mol. Neurosci. 5:13.doi: 10.3389/fnmol.2012.00013.
26. Brennan, B. P., Hudson, J. I., Jensen, J. E., McCarthy, J., Roberts, J. L., Prescot, A. P., et al. (2010). Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 834-846.doi: 10.1038/npp.2009.191.
27. Buchsbaum, M. S., Wu, J., Siegel, B. V., Hackett, E., Trenary, M., Abel, L., et al. (1997). Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol. Psychiatry 41, 15-22.doi: 10.1016/s0006-3223(96)00097-2.
28. Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., et al. (2008). A transcriptome database for astrocytes, neurons and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278.doi: 10.1523/JNEUROSCI.4178-07.2008.
29. Carrey, N. J., MacMaster, F. P., Gaudet, L., and Schmidt, M. H. (2007). Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 17, 11-17.doi: 10.1089/cap.2006.0008.
30. Catches, J. S., Xu, J., and Contractor, A. (2012). Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice. Behav. BrainRes. 228, 406-414.doi: 10.1016/j.bbr.2011.12.026.
31. Chen, Y., Peng, L., Zhang, X., Stolzenburg, J. U., and Hertz, L. (1995). Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells. Brain Res. Bull. 38, 153-159.doi: 10.1016/0361-9230(95)00082-p.
32. Choi, D. S., and Maroteaux, L. (1996). Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system and brain. FEBS. Lett. 391, 45-51.doi: 10.1016/0014-5793(96)00695-3.
33. Chowdhury, G. M., Banasr, M., de Graaf, R. A., Rothman, D. L., Behar, K. L., and Sanacora, G. (2008). Chronic riluzole treatment increases glucose metabolism in rat prefrontal cortex and hippocampus. J. Cereb. Blood FlowMetab. 28, 18921897.doi: 10.1038/jcbfm.2008.78.
34. Chowdhury, G. M., Behar, K. L., Cho, W., Thomas, M. A., Rothman, D. L., and Sanacora, G. (2012). 1H-[13C]-nuclear magnetic resonance spectroscopy measures ofketamine’s effect on amino acid neurotransmitter metabolism. Biol. Psychiatry 71, 1022-1025.doi: 10.1016/j.biopsych.2011.11.006.
35. Chowdhury, G. M., Jiang, L., Rothman, D. L., and Behar, K. L. (2014). The contribution of ketone bodies to basal and activity-dependent neuronal oxidationinvivo. J. Cereb. BloodFlowMetab. 34, 1233-1242.doi: 10.1038/jcbfm.2014.77.
36. Cohen, M. L., and Fludzinski, L. A. (1987). Contractile serotonergic receptor in rat stomach fundus. J. Pharmacol. Exp. Ther. 243, 264-269..
37. Cruz, N.F., Ball, K. K., and Dienel, G. A. (2007). Functional imaging of focal brain activation in conscious rats: impact of [(14)C]glucose metabolite spreading and release. J. Neurosci. Res. 85, 3254-3266.doi: 10.1002/jnr.22077.
38. Cryan, J. F., and Lucki, I. J. (2000). Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. Pharmacol. Exp. Ther. 295, 1120-1126..
39. Daub, H., Wallasch, C., Lankenau, A., Herrlich, A., and Ullrich, A. (1997). Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16, 70327044.doi: 10.1093/emboj/16.23.7032.
40. Deecher, D. C, Wilcox, B. D., Dave, V, Rossman, P.A., andKimelberg, H. K. (1993). Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis and Ca2+ responses in rat primary astrocyte cultures. J. Neurosci. Res. 35, 246-256.doi: 10.1002/jnr.490350304.
41. Delorme, R., Krebs, M. O., Chabane, N., Roy, I., Millet, B., Mouren-Simeoni, M. C., et al. (2004). Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport 15, 699-702.doi: 10.1097/00001756-200403220-00025.
42. Denton, R. M., and McCormack, J. G. (1990). Ca2+ as a second messenger within mitochondria of the heart and other tissues. Annu. Rev. Physiol. 52, 451-466.doi: 10.1146/annurev.physiol.52.1.451.
43. De Sarno, P., Li, X., and Jope, R. S. (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158-1164.doi: 10.1016/s0028-3908(02)00215-0.
44. Descarries, L., and Riad, M. (2012). Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. Philos. Trans. R. Soc. Lond.BBiol. Sci. 367, 2416-2425.doi: 10.1098/rstb.2011.0361.
45. Diaz, S. L., Doly, S., Narboux-Neme, N., Fernandez, S., Mazot, P., Banas, S. M., et al.(2012)5-HT(2B) receptors are required for serotonin-selective antidepressant actions. Mol. Psychiatry17, 154-163.doi: 10.1038/mp.2011.159.
46. Du, T., Li, B., Liu, S., Zang, P., Prevot, V., Hertz, L., et al. (2009). ERK phosphorylation in intact, adult brain byalpha(2)-adrenergic transactivation of EGF receptors. Neurochem. Int. 55, 593-600.doi: 10.1016/j.neuint.2009.05.016.
47. Du, T., Liang, C., Li, B., Hertz, L., and Peng, L. (2014). Chronic fluoxetine administration increases expression of the L-channel gene Cav1.2 in astrocytes from the brain of treated mice and in culture and augments K(+)-induced increase in [Ca(2+)]i. Cell Calcium 55, 166-174.doi: 10.1016/j.ceca.2014.01.002.
48. Duarte, J. M., and Gruetter, R. (2013). Glutamatergic and GABAergic energy metabolism measured in the rat brain by (13) C NMR spectroscopy at 14.1 T. J. Neurochem. 126, 579-590.doi: 10.1111/jnc.12333.
49. Duran, J., Saez, I., Gruart, A., Guinovart, J. J., and Delgado-Garcia, J. M. (2013). Impairment in long-term memory formation and learning-dependent synaptic plasticity in mice lacking glycogen synthase in the brain. J. Cereb. Blood Flow Metab. 33, 550-556.doi: 10.1038/jcbfm.2012.200.
50. Eid, T., Behar, K., Dhaher, R., Bumanglag, A. V., and Lee, T.-S. (2012). Roles of glutamine synthetase inhibition in epilepsy. Neurochem. Res. 37, 2339-2350.doi: 10.1007/s11064-012-0766-5.
51. Ellfolk, M., and Malm, H. (2010). Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod. Toxicol. 30, 249-260.doi: 10.1016/j.reprotox.2010.04.015.
52. Embi, N., Rylatt, D. B., and Cohen, P. (1980). Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527.doi: 10.1111/j.1432-1033.1980.tb06059.x.
53. Englander, M. T., Dulawa, S. C., Bhansali, P., and Schmauss, C. (2005). How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J. Neurosci. 25, 648-651.doi: 10.1523/jneurosci.3895-04.2005.
54. Eom, T. Y., and Jope, R. S. (2009). Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation. Biol. Psychiatry 66, 494-502.doi: 10.1016/j.biopsych.2009.04.015.
55. Fang, C. H., Li, B. G., James, J. H., King, J. K., Evenson, A. R., Warden, G. D., et al..(2005) Protein breakdown in muscle from burned rats is blocked by insulinlike growth factor i and glycogen synthase kinase-3beta inhibitors. Endocrinology 146, 3141-3149.doi: 10.1210/en.2004-0869.
56. Fava, M., and Rosenbaum, J. F. (1991). Suicidality and fluoxetine: is there a relationship? J. Clin. Psychiatry 52, 108-111..
57. Felder, C. C., Kanterman, R. Y., Ma, A. L., and Axelrod, J. (1990). Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl. Acad. Sci. USA 87, 2187-2191.doi: 10.1073/pnas.87.6.2187.
58. Freitas, A. E., Machado, D. G., Budni, J., Neis, V. B., Balen, G. O., Lopes, M. W., et al.(2013) Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticityin olfactorybulbectomized mice. Behav. Brain Res. 237, 176-184.doi: 10.1016/j.bbr.2012.09.035.
59. Fuller, R. W., and Wong, D. T. (1977). Inhibition of serotonin reuptake. Fed. Proc. 2154-2158..
60. Gaspers, L.D., and Thomas, A. P. (2008). Calcium-dependent activation of mitochondrial metabolism in mammalian cells. Methods 46, 224-232.doi: 10.1016/j.ymeth.2008.09.012.
61. Ge, W. P., Miyawaki, A., Gage, F. H., Jan, Y. N., and Jan, L. Y. (2012). Local generation of glia is a major astrocyte source in postnatal cortex. Nature 484, 376-380.doi: 10.1038/nature10959.
62. Gibbs, M. E., and Hertz, L. (2014). Serotonin mediation of early memory formation via 5-HT2B receptor-induced glycogenolysis in the day-old chick. Front. Pharmacol. 5:54.doi: 10.3389/fphar.2014.00054.
63. Gibbs, M. E., and Hutchinson, D. S. (2012). Rapid turnover of glycogen in memory formation. Neurochem. Res. 37, 2456-2463.doi: 10.1007/s11064-012-0805-2.
64. Gibbs, M. E., Hutchinson, D., and Hertz, L. (2008). Astrocytic involvement in learning and memory consolidation. Neurosci. Biobehav. Rev. 32, 927-944.doi: 10.1016/j.neubiorev.2008.02.001.
65. Gibbs, M. E., Lloyd, H. G., Santa, T., and Hertz, L. (2007). Glycogen is a preferred glutamate precursor during learning in 1-day-old chick: biochemical and behavioral evidence. J. Neurosci. Res. 85, 3326-3333.doi: 10.1002/jnr.21307.
66. Gosselin, R. D., Gibney, S., O’Malley, D., Dinan, T. G., and Cryan, J. F. (2009). Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 159, 915-925.doi: 10.1016/j.neuroscience.2008.10.018.
67. Gould, T. D., Picchini, A. M., Einat, H., and Manji, H. K. (2006). Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr. Drug Targets 7, 1399-1409.doi: 10.2174/1389450110607011399.
68. Griffin, L. D., and Mellon, S. H. (1999). Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. USA 96, 13512-13517.doi: 10.1073/pnas.96.23.13512.
69. Guirado, R., Sanchez-Matarredona, D., Varea, E., Crespo, C., Blasco-Ibanez, J. M., and Nacher, J. (2012). Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci. 13:5.doi: 10.1186/1471-2202-13-5.
70. Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., and Schmauss, C. (2002). Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34, 349-356.doi: 10.1016/s0896-6273(02)00660-8.
71. Halestrap, A.P. (1989). The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta. 973, 355-382.doi: 10.1016/s0005-2728(89)80378-0.
72. Hashimoto, K., Sawa, A., and Iyo, M. (2007). Increased levels of glutamate in brains of patients with mood disorders. Biol. Psychiatry 25, 1310-1316.doi: 10.1016/j.biopsych.2007.03.017.
73. Hertz, L. (2011). Astrocytic energy metabolism and glutamate formation-relevance for 13C-NMR spectroscopy and importance of cytosolic/mitochondrial trafficking. Magn. Reson. Imaging 29, 1319-1329.doi: 10.1016/j.mri.2011.04.013.
74. Hertz, L. (2013). The Glutamate-Glutamine (GABA) cycle: importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation. Front. Endocrinol. (Lausanne) 4:59.doi: 10.3389/fendo.2013.00059.
75. Hertz, L., Baldwin, F., and Schousboe, A. (1979). Serotonin receptors on astrocytes in primary cultures: effects of methysergide and fluoxetine. Can. J. Physiol. Pharmacol. 57, 223-226.doi: 10.1139/y79-034.
76. Hertz, L., Gerkau, N. J., Xu, J., Durry, S., Song, D., Rose, C., et al. (2014b). Roles of astrocytic Na+,K+-ATPase and glycogenolysis for K+ homeostasis in mammalian brain. J. Neurosci. Res.doi: 10.1002/jnr.23499.[Epub ahead of print]..
77. Hertz, L., Li, B., Song, D., Ren, J., Dong, L., Chen, Y., et al. (2012). Astrocytes as a 5-HT2B-mediated, SERT-independent SSRI target, slowly altering depression-associated genes and functions. Curr. Signal Transduct. Ther. 7, 65-80.doi: 10.2174/1574362799278154.
78. Hertz, L., Lovatt, D., Goldman, S. A., and Nedergaard, M. (2010). Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i. Neurochem. Int. 57, 411-420.doi: 10.1016/j.neuint.2010.03.019.
79. Hertz, L., Song, D., Li, B., Du, T., Xu, J., Gu, L., et al. (2014a). Signal transduction in astrocytes during chronic or acute treatment with drugs (SSRIs; anti-bipolar drugs; GABA-ergic drugs; benzodiazepines) ameliorating mood disorders. J. Signal Transduct. 2014:593934.doi: 10.1155/2014/593934.
80. Hertz, L., Xu, J., Song, D., Du, T., Li, B., Yan, E., et al. (2015). Astrocytic glycogenolysis: mechanisms and functions. Metab. Brain Dis. 30, 317-333.doi: 10.1007/s11011-014-9536-1.
81. Hertz, L., Xu, J., Song, D., Du, T., Yan, E., and Peng, L. (2013a). Brain glycogenolysis, adrenoceptors, pyruvate carboxylase, Na(+),K(+)-ATPase and Marie E. Gibbs’ pioneering learning studies. Front. Integr. Neurosci. 7:20.doi: 10.3389/fnint. 2013.00020.
82. Hertz, L., Xu, J., Song, D., Yan, E., Gu, L., and Peng, L. (2013b). Astrocytic and neuronal accumulation of elevated extracellular K(+) with a 2/3 K(+)/Na(+) flux ratio-consequences for energy metabolism, osmolarity and higher brain function. Front. Comput. Neurosci. 7:114.doi: 10.3389/fncom.2013.00114.
83. Hertz, L., and Zielke, H. R. (2004). Astrocytic control of glutamatergic activity: astrocytes as stars of the show. TrendsNeurosci. 27, 735-743.doi: 10.1016/j.tins.2004.10.008.
84. Huang, R., Chen, Y., Yu, A. C., and Hertz, L. (2000). Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity. J. Cereb. Blood Flow Metab. 20, 895-898.doi: 10.1097/00004647-200006000-00001.
85. Huang, R., and Hertz, L. (1995). Noradrenaline-induced stimulation of glutamine metabolism in primary cultures of astrocytes. J. Neurosci. Res. 41, 677-683.doi: 10.1002/jnr.490410514.
86. Hyder, F., and Rothman, D. L. (2012). Quantitative fMRI and oxidative neuroenergetics. Neuroimage 62, 985-994.doi: 10.1016/j.neuroimage.2012.04.027.
87. Jenck, F., Bos, M., Wichmann, J., Stadler, H., Martin, J. R., and Moreau, J. L. (1998). The role of 5-HT2C receptors in affective disorders. Expert Opin. Investig. Drugs 1587-1599.doi: 10.1517/13543784.7.10.1587.
88. Johnson, D. A., Ingram, C. D., Grant, E. J., Craighead, M., and Gartside, S. E. (2009). Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter. Neuropsychopharmacology 34, 399409.doi: 10.1038/npp.2008.70.
89. Kanner, A. M. (2014). Is depression associated with an increased risk of treatment-resistant epilepsy? Research strategies to investigate this question. Epilepsy Behav. 3-7.doi: 10.1016/j.yebeh.2014.06.027.
90. Kennedy, S. H., Evans, K. R., Kruger, S., Mayberg, H. S., Meyer, J. H., McCann, S., et al. (2001). Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am. J. Psychiatry158, 899-905.doi: 10.1176/appi.ajp.158.987.899.
91. Kennett, G. A., Wood, M. D., Bright, F., Trail, B., Riley, G., Holland, V., et al. (1997). SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36, 609-620.doi: 10.1016/s0028-3908(97)00038-5.
92. Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., Willis, M. W., et al. (2002). Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol. Psychiatry 51, 237-252.doi: 10.1016/S0006-3223(01)01216-1.
93. Kiyokage, E., Toida, K., Suzuki-Yamamoto, T., and Ishimura, K. (2014). Cellular localization of 5a-reductase in the rat cerebellum. J. Chem. Neuroanat. 59-60, 8-16.doi: 10.1016/j.jchemneu.2014.04.002.
94. Kong, E. K., Peng, L., Chen, Y., Yu, A. C. H., and Hertz, L. (2002). Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Res. 27,113-120.doi: 10.1023/A:1014862808126.
95. Kraus, J. E., Horrigan, J. P., Carpenter, D. J., Fong, R., Barrett, P. S., and Davies, J. T. (2010). Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. J. Affect. Disord. 120, 40-47.doi: 10.1016/j.jad.2009.04.004..
96. Kursar, J. D., Nelson, D. L., Wainscott, D. B., and Baez, M. (1994). Molecular cloning, functional expression and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol. Pharmacol. 46, 227-234..
97. Langer, S. Z., Galzin, A. M., Lee, C. R., andSchoemaker, H. (1986). Antidepressant-binding sites in brain and platelets. Ciba Found. Symp. 123, 3-29..
98. Lanz, B., Gruetter, R., and Duarte, J. M. (2013). Metabolic flux and compartmentation analysis in the brain in vivo. Front. Endocrinol. (Lausanne) 4:156.doi: 10.3389/fendo.2013.00156.
99. Launay, J. M., Schneider, B., Loric, S., Da Prada, M., and Kellermann, O..(2006) Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells. FASEB J. 20, 1843-1854.doi: 10.1096/fj.06-5724com.
100. Lautens, L. L., Chiou, X. G., Sharp, J. D., Young, W. S. 3rd, Sprague, D. L., Ross, L. S., et al. (1998). Cytosolic phospholipase A2 (cPLA2) distribution in murine brain and functional studies indicate that cPLA2 does not participate in muscarinic receptor-mediated signaling in neurons. Brain Res. 809, 18-30.doi: 10.1016/s0006-8993(98)00806-3.
101. Lebon, V., Petersen, K. F., Cline, G. W., Shen, J., Mason, G. F., Dufour, S., et al. (2002). Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J. Neurosci. 22, 1523-1531..
102. Lee, Y., Son, H., Kim, G., Kim, S., Lee, D. H., Roh, G. S., et al. (2013). Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice. J. Psychiatry Neurosci. 38, 183-191.doi: 10.1503/jpn.120024.
103. Le Poul, E., Boni, C., Hanoun, N., Laporte, A. M., Laaris, N., Chauveau, J., et al. (2000). Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronicallywith fluoxetine. Neuropharmacology 110-122.doi: 10.1016/s0028-3908(99)00088-x.
104. Lesch, K. P., Aulakh, C. S., Wolozin, B. L., Tolliver, T. J., Hill, J. L., and Murphy, D. L. (1993). Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res. Mol. Brain Res. 17, 31-35.doi: 10.1016/0169-328x(93)90069-2.
105. Leysen, D.C.(1999). Selective 5-HT2C agonists as potential antidepressants. IDrugs 109-120..
106. Li, B., Dong, L., Fu, H., Wang, B., Hertz, L., and Peng, L. (2011b). Effects of chronic treatment with fluoxetine on receptor-stimulated increase of [Ca2+] in astrocytes mimic those of acute inhibition of TRPC1 channel activity. Cell Calcium 50, 42-53.doi: 10.1016/j.ceca.2011.05.001.
107. Li, B., Dong, L., Wang, B., Cai, L., Jiang, N., and Peng, L. (2012). Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia. Neurochem. Res. 37, 2480-2495.doi: 10.1007/s11064-012-0814-1.
108. Li, B., Du, T., Li, H., Gu, L., Zhang, H., Huang, J., et al. (2008b). Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons. Br. J. Pharmacol. 154, 191-203.doi: 10.1038/bjp.2008.58.
109. Li, B., Gu, L., Hertz, L., and Peng, L. (2013). Expression of nucleoside transporter in freshly isolated neurons and astrocytes from mouse brain. Neurochem. Res. 38,2351-2358.doi: 10.1007/s11064-013-1146-5.
110. Li, X., and Jope, R. S. (2010). Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35, 2143-2154.doi: 10.1038/npp.2010.105.
111. Li, B., Zhang, S., Li, M., Hertz, L., and Peng, L. (2009). Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology (Berl) 207, 1-12.doi: 10.1007/s00213-009-1631-3.
112. Li, B., Zhang, S., Zhang, H., Hertz, L., and Peng, L. (2011a). Fluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes. J. Psychiatry Neurosci. 36, 322-338.doi: 10.1503/jpn.100094.
113. Li, B., Zhang, S., Zhang, H., Nu, W., Cai, L., Hertz, L., et al. (2008a). Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berl) 201, 443458.doi: 10.1007/s00213-008-1306-5.
114. Li, X., Zhu, W., Roh, M. S., Friedman, A. B., Rosborough, K., and Jope, R. S. (2004). In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activityin mouse brain. Neuropsychopharmacology 29, 1426-1431.doi: 10.1038/sj.npp.1300439.
115. Lightowler, S., Kennett, G. A., Williamson, I. J., Blackburn, T. P., and Tulloch, F. (1994). Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol. Biochem. Behav. 49, 281-285.doi: 10.1016/0091-3057(94)90422-7.
116. Little, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B. E., Willis, M. W., et al. (1996). Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol. Bull. 32, 629-635..
117. Little, J. T., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Benson, B. E., Willis, M. W., et al. (2005). Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biol. Psychiatry 57, 220228.doi: 10.1016/j.biopsych.2004.10.033.
118. Lovatt, D., Sonnewald, U., Waagepetersen, H. S., Schousboe, A., He, W., Lin, J. H., et al. (2007). The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J. Neurosci. 27, 12255-12266.doi: 10.1523/jneurosci.3404-07.2007.
119. Manev, H., Uz, T., and Manev, R. (2003). Glia as a putative target for antidepressant treatments. J. Affect. Disord. 75, 59-64.doi: 10.1016/s0165-0327(02) 00044-7.
120. Mangia, S., Giove, F., and Dinuzzo, M. (2012). Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain. Neurochem. Res. 37,2554-2561.doi: 10.1007/s11064-012-0848-4.
121. Mangia, S., Giove, F., and Dinuzzo, M. (2013). K+ homeostasis in the brain: anew role for glycogenolysis. Neurochem. Res. 38, 470-471.doi: 10.1007/s11064-012-0962-3.
122. Martin, J. R., Bos, M., Jenck, F., Moreau, J., Mutel, V., Sleight, A. J., et al. (1998). 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther. 286, 913-924..
123. Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., et al. (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 48, 830-843.doi: 10.1016/s0006-3223(00)01036-2.
124. Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramauge, M., Courtin,, et al. (2004). MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 24, 207-216.doi: 10.1385/jmn:24:2:207.
125. Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., et al. (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am. J. Psychiatry 161, 826-835.doi: 10.1176/appi.ajp.161.5.826.
126. Mitani, H., Shirayama, Y., Yamada, T., Maeda, K., Ashby, C. R. Jr., and Kawahara, R.(2006). Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 11551158.doi: 10.1016/j.pnpbp.2006.03.036.
127. Muguruza, C., Miranda-Azpiazu, P., Diez-Alarcia, R., Morentin, B., Gonzalez-Maeso, J., Callado, L. F., et al. (2014). Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment. Neuropharmacology 86, 311-318.doi: 10.1016/j.neuropharm.2014.08.009.
128. Murakami, M., Shimbara, S., Kambe, T., Kuwata, H., Winstead, M. V., Tischfield, J. A., et al. (1998). The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273, 14411-14423.doi: 10.1074/jbc.273.23. 14411.
129. Niciu, M. J., Henter, I. D., Luckenbaugh, D. A., Zarate, C. A. Jr., and Charney, D. S.. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu. Rev. Pharmacol. Toxicol. 54, 119-139.doi: 10.1146/annurev-pharmtox-011613-135950.
130. Nierenberg, A. A., Farabaugh, A. H., Alpert, J. E., Gordon, J., Worthington, J. J., Rosenbaum, J. F., et al. (2000). Timing of onset of antidepressant response with fluoxetine treatment. Am. J. Psychiatry 157, 1423-1428.doi: 10.1176/appi.ajp. 157.9.1423.
131. Nissen-Meyer, L. S., and Chaudhry, F. A. (2013). Protein Kinase C Phosphorylates the System N Glutamine Transporter SN1 (Slc38a3) and regulates its membrane trafficking and degradation. Front. Endocrinol. (Lausanne) 4:138.doi: 10.3389/fendo.2013.00138.
132. Niswender, C. M., Herrick-Davis, K., Dilley, G. E., Meltzer, H. Y., Overholser, J. C., Stockmeier, C. A., et al. (2001). RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24, 478-491.doi: 10.1016/s0893-133x(00)00223-2.
133. Obel, L. F., Muller, M. S., Walls, A. B., Sickmann, H. M., Bak, L. K., Waagepetersen, H. S., et al. (2012). Brain glycogen-new perspectives on its metabolic function and regulation at the subcellular level. Front. Neuroenergetics 4:3.doi: 10.3389/fnene.2012.00003.
134. O’Connor, R. M., Pusceddu, M. M., Dinan, T. G., and Cryan, J. F. (2013). Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment. Neuropharmacology 66, 236-241.doi: 10.1016/j.neuropharm.2012. 05.006.
135. O’Leary, O. F., Dinan, T. G., and Cryan, J. F. (2014). Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur. J. Pharmacol.doi: 10.1016/j.ejphar.2014.07.046. [Epub aheadofprint]..
136. Oyagi, A., Moriguchi, S., Nitta, A., Murata, K., Oida, Y., Tsuruma, K., et al. (2011). Heparin-binding EGF-like growth factor is required for synaptic plasticity and memory formation. Brain Res. 1419, 97-104.doi: 10.1016/j.brainres.2011. 09.003.
137. Pae, C. U., Yu, H. S., Kim, J. J., Lee, C. U., Lee, S. J., Lee, K. U., et al..(2004) BanI polymorphism of the cytosolic phospholipase A2 gene and mood disorders in the Korean population. Neuropsychobiology 49, 185-188.doi: 10.1159/000077364.
138. Palaiologos, G., Hertz, L., and Schousboe, A. (1989). Role of aspartate aminotransferase and mitochondrial dicarboxylate transport for release of endogenously and exogenously supplied neurotransmitter in glutamatergic neurons. Neurochem. Res. 14, 359-366.doi: 10.1007/bf01000039.
139. Patel, A. B., de Graaf, R. A., Mason, G. F., Rothman, D. L., Shulman, R. G., and Behar, K. L. (2005). The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc. Natl. Acad. Sci. USA 102, 5588-5593.doi: 10.1073/pnas.0501703102.
140. Patel, A. B., de Graaf, R. A., Rothman, D. L., and Behar, K. L. (2015). Effects of GAT1 inhibtion by tiagabine on brain glutamate and GABA metabolism in the anesthetized rat in vivo. J. Neurosci. Res..
141. Peavy, R. D., Chang, M. S., Sanders-Bush, E., and Conn, P. J. (2001). Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J. Neurosci. 21, 9619-9628..
142. Peca, S., Carni, M., Di Bonaventura, C., Aprile, T., Hagberg, G. E., Giallonardo, A. T., et al. (2010). Metabolic correlatives of brain activity in a FOS epilepsy patient. NMR Biomed. 23, 170-178.doi: 10.1002/nbm.1439.
143. Peng, L. (2004). “Transactivation in astrocytes as a novel mechanism of neuroprotection,” in Non-neuronal Cells of the Nervous System: Function and Dysfunction, ed L. Hertz (Amsterdam: Elsevier), 503-518..
144. Peng, L., Gu, L., Li, B., and Hertz, L. (2014). Fluoxetine and all other SSRIs are 5-HT2B Agonists-Importance for their therapeutic effects. Curr. Neuropharmacol. 12, 365-379.doi: 10.2174/1570159x12666140828221720.
145. Pinna, G., Costa, E., and Guidotti, A. (2009). SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr. Opin. Pharmacol. 9, 24-30.doi: 10.1016/j.coph.2008.12.006.
146. Plenge, P. (1976). Acute lithium effects on rat brain glucose metabolism-in vivo. Int. Pharmacopsychiatry 11, 84-92..
147. Plenge, P. (1982). Lithium effects on rat brain glucose metabolism in vivo. Effects after administration of lithium by various routes. Psychopharmacology (Berl) 77, 348-355.doi: 10.1007/bf00432769.
148. Polter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., et al. (2010). Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 35, 1761-1774.doi: 10.1038/npp.2010.43.
149. Polter, A. M., Yang, S., Jope, R. S., and Li, X. (2012). Functional significance of glycogen synthase kinase-3 regulation by serotonin. Cell Signal. 24, 265-271.doi: 10.1016/j.cellsig.2011.09.009.
150. Popik, P. (1999). Preclinical pharmacology of citalopram. J. Clin. Psychopharmacol. 19, 4S-22S.doi: 10.1097/00004714-199910001-00002.
151. Porter, R. H., Benwell, K. R., Lamb, H., Malcolm, C. S., Allen, N. H., Revell, D. F., et al. (1999). Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br. J. Pharmacol. 128, 13-20.doi: 10.1038/sj.bjp.0702751.
152. Pugh, K. R., Frost, S. J., Rothman, D. L., Hoeft, F., Del Tufo, S. N., Mason, F., et al. (2014). Glutamate and choline levels predict individual differences in reading ability in emergent readers. J. Neurosci. 34, 4082-4089.doi: 10.1523/JNEUROSCI.3907-13.2014.
153. Qu, Y., Chang, L., Klaff, J., Seemann, R., and Rapoport, S. I. (2003). Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats. Neuropsychopharmacology 28, 1219-1226.doi: 10.1038/sj.npp.1300177.
154. Rajkowska, G., and Stockmeier, C. A. (2013). Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets14, 1225-1236.doi: 10.2174/13894501113149990156.
155. Rao, J. S., Ertley, R. N., Lee, H. J., Rapoport, S. I., and Bazinet, R. P. (2006). Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex. Pharmacogenomics J. 6, 413-420.doi: 10.1038/sj.tpj.6500391.
156. Rapoport, S. I. (2008). Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids 79, 153-156.doi: 10.1016/j.plefa.2008.09.010.
157. Rasgon, N. L., Kenna, H. A., Geist, C., Small, G., and Silverman, D. (2008). Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder. Psychiatry Res. 164, 77-80.doi: 10.1016/j.pscychresns.2007.12.006.
158. Rieckmann, N., Kronish, I. M., Shapiro, P. A., Whang, W., and Davidson, K. W.. Serotonin reuptake inhibitor use, depression and long-term outcomes after an acute coronary syndrome: a prospective cohort study. JAMA Intern. Med. 173, 1150-1151.doi: 10.1001/jamainternmed.2013.910.
159. Rosenzweig-Lipson, S., Sabb, A., Stack, G., Mitchell, P., Lucki, I., Malberg, J. E., et al. (2007). Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents. Psychopharmacology (Berl) 192, 159-170.doi: 10.1007/s00213-007-0710-6.
160. Roth, B. L., Willins, D. L., Kristiansen, K., and Kroeze, W. K. (1998). 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol. Ther. 79, 231-257.doi: 10.1016/s0163-7258(98)00019-9.
161. Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kunci, R. W., et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.doi: 10.1016/s0896-6273(00)80086-0.
162. Rubio, F. J., Ampuero, E., Sandoval, R., Toledo, J., Pancetti, F., and Wyneken, U.. (2013) Long-term fluoxetine treatment induces input-specific LTP and LTD impairment and structural plasticity in the CA1 hippocampal subfield. Front. Cell. Neurosci. 7:66.doi: 10.3389/fncel.2013.00066.
163. Rutter, G. A., Burnett, P., Rizzuto, R., Brini, M., Murgia, M., Pozzan, T., et al.(1995). Subcellular imaging of intramitochondrial Ca2+ with recombinant targeted aequorin: significance for the regulation of pyruvate dehydrogenase activity. Proc. Natl. Acad. Sci. USA 93, 5489-5494.doi: 10.1073/pnas.93. 11.5489.
164. Sampaio, A. S., Fagerness, J., Crane, J., Leboyer, M., Delorme, R., Pauls, D. L., et al. (2011). Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study. CNS Neurosci. Ther. 17, 141-147.doi: 10.1111/j.1755-5949.2009.00130.x.
165. Sanacora, G., and Banasr, M. (2013). From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol. Psychiatry 73, 1172-1179.doi: 10.1016/j.biopsych.2013. 03.032.
166. Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y. T., Appel, M., Rothman, D. L., et al. (2004). Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 61, 705713.doi: 10.1001/archpsyc.61.7.705.
167. Sanacora, G., Kendell, S. F., Levin, Y., Simen, A. A., Fenton, L. R., Coric, V., et al. (2007). Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol. Psychiatry 61, 822-825.doi: 10.1016/j.biopsych.2006.08.037.
168. Sanacora, G., Mason, G. F., Rothman, D. L., and Krystal, J. H. (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective Serotonin Reuptake inhibitors. Am. J. Psychiatry159, 663-665.doi: 10.1176/appi.ajp.159.4.663.
169. Sanacora, G., Treccani, G., and Popoli, M. (2012). Towards a glutamate hypothesis of depression an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62, 63-77.doi: 10.1016/j.neuropharm.2011.07.036.
170. Sands, S. A., Reisman, S. A., and Enna, S. J. (2004). Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus. Biochem. Pharmacol. 68, 1489-1495.doi: 10.1016/j.bcp.2004.07.027.
171. Sarkar, A., Chachra, P., and Vaidya, V. A. (2014). Postnatal fluoxetine-evoked anxiety is prevented by Concomitant 5-HT(2A/C) receptor blockade and mimicked by postnatal 5-HT(2A/C) receptor stimulation. Biol. Psychiatry 76, 858-868.doi: 10.1016/j.biopsych.2013.11.005.
172. Schaeffer, E.L., and Gattaz, W. F. (2008). Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) 198, 1-27.doi: 10.1007/s00213-008-1092-0.
173. Schipke, C. G., Heuser, I., and Peters, O. (2011). Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J. Psychiatr. Res. 45, 242-248.doi: 10.1016/j.jpsychires.2010.06.005.
174. Schmauss, C., Zimnisky, R., Mehta, M., and Shapiro, L. P. (2010). The roles of phospholipase C activation and alternative ADAR1 and ADAR2 pre-mRNA splicing in modulating serotonin 2C-receptor editing in vivo. RNA 16, 17791785.doi: 10.1261/rna.2188110.
175. Schousboe, A. (1971). Development of potassium effects on ion concentrations and indicator spaces in rat brain-cortex slices during postnatal ontogenesis. Exp. Brain Res. 15, 521-531.doi: 10.1007/bf00236406.
176. Schousboe, A., Bak, L. K., and Waagepetersen, H. S. (2013). Astrocytic control of Biosynthesis and turnover of the Neurotransmitters Glutamate and GABA. Front. Endocrinol. (Lausanne) 4:102.doi: 10.3389/fendo.2013. 00102.
177. Shaltiel, G., Maeng, S., Malkesman, O., Pearson, B., Schloesser, R. J., Tragon, T., et al. (2008). Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol. Psychiatry 13, 858-872.doi: 10.1038/mp.2008.20.
178. Shank, R. P., Bennett, G. S., Freytag, S. O., and Campbell, G. L. (1985). Pyruvate carboxylase:anastrocyte-specificenzymeimplicatedinthereplenishmentof amino acidneurotransmitterpools. BrainRes. 329, 364–367.doi:10.1016/0006-8993(85)90552-9.
179. Sibson, N.R., Dhankhar, A., Mason, G. F., Rothman, D. L., Behar, K. L., and Shulman, R. G. (1998). Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. USA 95, 316-321.doi: 10.1073/pnas.95.1.316.
180. Singh, A. B., Bousman, C. A., Ng, C. H., and Berk, M. (2013). High impact child abuse may predict risk of elevated suicidality during antidepressant initiation. Aust. NZ J. Psychiatry 47, 1191-1195.doi: 10.1177/0004867413510212.
181. Sonnewald, U. (2014). Glutamate synthesis has to be matched by its degradation-where do all the carbons go? J. Neurochem. 131, 399-406.doi: 10.1111/jnc.12812.
182. Sorg, O., Pellerin, L., Stolz, M., Beggah, S., and Magistretti, P. J. (1995). Adenosine triphosphate and arachidonic acid stimulate glycogenolysis in primary cultures of mouse cerebral cortical astrocytes. Neurosci. Lett. 188, 109-112.doi: 10.1016/0304-3940(95)11410-x.
183. Subbarao, K. V., and Hertz, L. (1991). Stimulation of energy metabolism byalpha-adrenergic agonists in primary cultures of astrocytes. J. Neurosci. Res. 28, 399405.doi: 10.1002/jnr.490280312.
184. Sublette, M. E., Milak, M. S., Hibbeln, J. R., Freed, P. J., Oquendo, M. A., Malone, K. M., et al. (2009). Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. Prostaglandins Leukot. Essent. Fatty Acids 80, 57-64.doi: 10.1016/j.plefa.2008.11.004.
185. Sun, G. Y., Xu, J., Jensen, M. D., and Simonyi, A. (2004). Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid. Res. 45,205-213.doi: 10.1194/jlr.r300016-jlr200.
186. Trivedi, M. H., Wisniewski, S. R., Morris, D. W., Fava, M., Kurian, B. T., Gollan, J. K., et al. (2011). Concise associatedsymptoms trackingscale:abriefself-report and clinician rating of symptoms associated with suicidality. J. Clin. Psychiatry 72, 765-774.doi: 10.4088/jcp.11m06840.
187. Verkhratsky, A., Nedergaard, M., and Hertz, L. (2014). Why are astrocytes important? Neurochem. Res.doi: 10.1007/s11064-014-1403-2. [Epub ahead of print]..
188. Vialou, V., Robison, A. J., Laplant, Q. C., Covington, H. E. 3rd, Dietz, D. M., Ohnishi, Y. N., et al. (2010). DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat. Neurosci. 13, 745-752.doi: 10.1038/nn.2551.
189. Vicente, M. A., and Zangrossi, H. Jr. (2014). Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment. Neuropharmacology 79, 127-135.doi: 10.1016/j.neuropharm.2013.11.007.
190. Videbech, P. (2000). PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr. Scand. 101, 11-20.doi: 10.1034/j.1600-0447.2000.101001011.x.
191. Webhofer, C., Gormanns, P., Reckow, S., Lebar, M., Maccarrone, G., Ludwig, T., et al. (2013). Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates. J. Psychiatr. Res. 47, 289-298.doi: 10.1016/j.jpsychires.2012.11.003.
192. Wei, S., Ong, W. Y., Thwin, M. M., Fong, C. W., Farooqui, A. A., Gopalakrishnakone, P., et al. (2003). Group IIA secretory phospholipase A2 stimulates exocytosis and neurotransmitter release in pheochromocytoma-12 cells and cultured rat hippocampal neurons. Neuroscience 121, 891-898.doi: 10.1016/s0306-4522(03)00525-6.
193. Wong, D. T., and Bymaster, F. P. (1995). Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors. Adv. Exp. Med. Biol. 363, 77-95.doi: 10.1007/978-1-4615-1857-0_11.
194. Xia, M., and Zhu, Y. (2011). Signaling pathways of ATP-induced PGE2 release in spinal cord astrocytes are EGFR transactivation-dependent. Glia 59, 664-674.doi: 10.1002/glia.21138.
195. Xu, J., Song, D., Bai, Q., Cai, L., Hertz, L., and Peng, L. (2014). Basic mechanism leading to stimulation of glycogenolysis by isoproterenol, EGF, elevated extracellular K+ concentrations, or GABA. Neurochem. Res. 39, 661667.doi: 10.1007/s11064-014-1244-z.
196. Xu, J., Song, D., Xue, Z., Gu, L., Hertz, L., and Peng, L. (2013). Requirement of glycogenolysis for uptake of increased extracellular K+ in astrocytes: potential implications for K+ homeostasis and glycogen usage in brain. Neurochem. Res. 38, 472-485.doi: 10.1007/s11064-012-0938-3.
197. Yan, E., Li, B., Gu, L., Hertz, L., and Peng, L. (2013). Mechanisms for L-channel-mediated increase in [Ca(2+)](i) and its reduction by anti-bipolar drugs in cultured astrocytes combined with its mRNA expression in freshly isolated cells support the importance of astrocytic L-channels. Cell Calcium 54, 335-342.doi: 10.1016/j.ceca.2013.08.002.
198. Yu, A. C., Drejer, J., Hertz, L., and Schousboe, A. (1983). Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J. Neurochem. 41, 14841487.doi: 10.1111/j.1471-4159.1983.tb00849.x.
199. Yu, N., Martin, J. L., Stella, N., and Magistretti, P. J. (1993). Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc. Natl. Acad. Sci. US A 90, 4042-4046.doi: 10.1073/pnas.90.9.4042.
200. Zhang, S., Li, B., Lovatt, D., Xu, J., Song, D., Goldman, S. A., et al. (2010). 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional ‘serotonin-specific reuptake inhibitors’. Neuron Glia Biol. 6, 113-125.doi: 10.1017/s1740925x10000141.
201. Zhang, X., Peng, L., Chen, Y., and Hertz, L. (1993). Stimulation of glycogenolysis in astrocytes by fluoxetine, an antidepressant acting like 5-HT. Neuroreport 4, 1235-1238.doi: 10.1097/00001756-199309000-00006.
202. Zhou, Z., Zhen, J., Karpowich, N. K., Law, C. J., Reith, M. E., and Wang, D. N. 2009 Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat. Struct. Mol. Biol. 16, 652-657.doi: 10.1038/nsmb.1602.